Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of revenue | $0 | $0 |
| Gross profit | $0 | $0 |
| Gross margin | — | — |
| R&D | $0 | $0 |
| Operating income | −$175.0K | −$269.0K |
| EBITDA | $8.6K | $17.7K |
| Net income | −$167.0K | −$251.0K |
| Net margin | — | — |
| EPS (diluted) | -0.03 | -0.03 |
Annual figures · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ARTOXAmerican Century One Choice In Retirement Portfolio;Investor | $13.01 | +0.39% | $2.4B | — |
| ALVIXAmerican Century Focused Lg Cap Val Inv | $11.28 | +0.00% | $2.9B | — |
| BREIXBaron Real Estate Fd Insti Shs | $43.29 | -0.28% | $2.2B | — |
| CFSIXTouchstone Sands Capital Select Growth Y | $21.51 | +2.48% | $2.3B | — |
| GSHIXGoldman Sachs High Yield Instl |
No one on the platform currently holds ARTOX.
No tracked institution reports a position in ARTOX as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-11 | $0.0744 | 2026-06-11 |
| 2026-03-12 | $0.0326 | 2026-03-12 |
| 2025-12-19 | $0.5325 | 2025-12-19 |
| 2025-09-25 | $0.0669 | 2025-09-25 |
| 2025-06-10 | $0.4616 | 2025-06-10 |
| 2025-03-27 | $0.0546 | 2025-03-27 |
| 2024-12-20 | $0.3522 | 2024-12-20 |
| 2024-09-24 | $0.0297 | 2024-09-24 |
| 2024-06-25 | $0.0656 | 2024-06-25 |
| 2024-03-26 | $0.0508 | 2024-03-26 |
| 2023-12-21 | $0.4003 |
No one on the platform has traded ARTOX yet.
| $5.62 |
| +0.18% |
| $2.5B |
| — |
| IALAXTransamerica Capital Growth A | $43.52 | +3.82% | $2.0B | — |
| PELAXPIMCO Emerging Mkts Lcl Ccy and Bd A | $6.28 | +0.16% | $2.7B | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2023-12-21 |
| 2023-09-26 | $0.0409 | 2023-09-26 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.